中关村(000931.SZ)：撤回氨酚羟考酮片药品注册申请

Core Viewpoint - The company Beijing Huasu Pharmaceutical Co., Ltd. has decided to withdraw its drug registration application for Oxycodone and Acetaminophen tablets to further improve the submission materials [1] Group 1: Company Actions - Beijing Huasu received a "Drug Registration Application Termination Notice" from the National Medical Products Administration, agreeing to withdraw the application for Oxycodone and Acetaminophen tablets [1] - The company plans to resubmit the drug registration application after enhancing the relevant research [1] Group 2: Regulatory Context - The withdrawal of the application is not an indication of termination of the project, but rather a step to refine the application process [1]